THE CASE OF SUCCESSFUL TREATMENT OF A CRISIS IN MYASTINIC TREATMENT IN A YOUNG PATIENT
Myasthenia is a chronic autoimmune disease, which determined by weakness and pathological tiredness of different groups of cross striated muscles causing neuromuscular conduction disorders. At the same time, critical conditions may arise in patients with myasthenia, requiring urgent measures, which maybe a cause of significant difficulties for physicians. Such disorders affecton the course of the disease and the mortalityrate [15]. Ananalysis of the clinical case of a patient with a mixed crisis (myasthenic and cholinergic) in myasthenia, the leading syndrome of which was respiratory failure is given. The described case of myasthenic crisisis interesting from the stand point of the causes, clinical course and effectiveness of the use of the crisis management algorithm, reflected in the clinical protocol No. 16 of November 29, 2016.
Nazira A. Zharkinbekova 1, http://orcid.org/0000-0002-5069-1562,
Almaz M. Mamirov 2, Barno B. Irgasheva 2
1 Department of Neurology, South Kazakhstan Medical Academy,
2 Resuscitation Department, Regional Clinical Hospital, Shymkent, Republic of Kazakhstan.
1. Бондаренко Л.А., Пенина Г.О. Эпидемиология, клинико-функциональные характеристики и качество жизни больных миастенией жителей европейского Севера // Междунар. Неврол. Журн. 2009. №1. С. 71–75.
2. Ишмухаметова А.Т., Мусин Р.Г., Хидиятова И.М. и др. Эпидемиологическое исследование миастении гравис в Республике Башкортостан // Неврологический журнал. 2006. № 6. С. 16–21.
3. Каймак Т.В., Калиева А.К., Тургамбаева А.Т., Бикбаев Р.М. Миастения: современные подходы к лечению // Наука и здравоохранение, 2014, № 2, С.45-48.
4. Копьева Т.Н., Секамова С.М., Шкроб О.С. и др. Морфология вилочковой железы при миастении у детей. В кн.: Физиология, морфология и патология тимуса. М., 1986. С. 69–74.
5. Кузин М.И., Гехт Б.М. Миастения. М: Медицина; 1996. 224 с.
6. Лайсек Р.П., Барчи Р.Л. Миастения. Москва: Медицина; 1984. 272 с.
7. Санадзе А.Г. Миастения и миастенические синдромы. Москва: Литера; 2012. 255 с.
8. Щербакова Н.И., Пирадов М.А., Павлова Е.М. и др. Причины, факторы риска, предикторы развития кризов у больных миастенией // Неврологический журнал. 2013;(2):11–9.
9. Albdewi M.A., Liistro G., El Tahry R. Sleep-disordered breathing in patients with neuromuscular disease // Sleep Breath. 2017, Jul., 12
10. Bedlack R.S., Sanders D.B. On the concept of myasthenic crisis. J ClinNeuromuscul Dis 2002;4(1):40–2. PMID: 19078687.
11. Cohen M.S., Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann NY AcadSci 1981;377:670 – 7. PMID: 6951491.
12. Fatigue in myasthenia gravis: risk factors and impact on quality of life / Sarah Hoffmann, Johanna Ramm, Ulrike Grittner, Siegfried Kohler, Jana Siedler, and Andreas Meisel // Brain Behav. 2016. Vol. 6, N10. P. e00538.
13. Fernandes Oliveira E., Nacif S.R., Alves Pereira N., Fonseca N.T., Urbano J.J., Perez E.A., Cavalcante V., Santos Oliveira C., Insalaco G., Oliveira A.S., Oliveira L.V. Sleep disorders in patients with myasthenia gravis: a systematic review // J. Phys. Ther. Sci. 2015. Vol. 27, N6. P. 2013–2018.
14. Jani-Acsadi A., Lisak R.P. Myasthenic crisis: guidelines for prevention and treatment. J NeurolSci 2007; 261(1–2):127–33. PMID: 17544450.
15. Juel V.C., Massey J.M. Myasthenia gravis //Orphanet J Rare Dis 2007;2:44. PMID: 17986328.
16. Oopik M., Kaasik A.E., Jakobsen J.J. A population based epidemiological study on myasthenia gravis in Estonia // Neurol. Neurosurg. Psychiatry. 2003. № 74. P. 1638–1643.
17. Poulas K., Tsibr E., Kokta A. et al. Epidemiology of seropositive myasthenia gravis in Greece // J. Neurol. Neurosurg. Psychiatry. 2001. № 71. P. 352–356.
References:
1. Bondarenko L.A., Penina G.O. Epidemiologiya, klinikofunktsional’nye kharakteristiki i kachestvo zhizni bol’nykh miasteniei zhitelei evropeiskogo Severa [Epidemiology, clinical and functional characteristics and quality of life of patients with myasthenia of the inhabitants of the European North]. Mezhdunarodnyi nevrologicheskii zhurnal. [International Neurological Journal]. 2009. № 1. pp. 71–75. [In Russian].
2. Ishmukhametova A.T., Musin R.G., Khidiyatova I.M. Epidemiologicheskoe issledovanie miastenii gravis v Respublike Bashkortostan [Epidemiological study of myasthenia gravis in the Republic of Bashkortostan]. Nevrologicheskii zhurnal. [Neurologic Journal]. 2006. № 6. pp. 16–21. [In Russian].
3. Kaymak T.V., Calieva A.K., Turgambaeva A.T., Bikbaev R.M.. Miastenia: sovremennye podkhody k lechenui [Myasthenia: modern approaches to treatment]. Nauka i zdravookhranenie [Science & Healthcare], 2014, №2, рр. 45-48 [In Russian].
4. Kop’evа Т.N., Sekamovа S.М., Shkrob О.S. I dr. Morfologiya vilochkovoi zhelezy pri miastenii u detei. V kn.: Fiziologiya, morfologiya i patologiya timusa. [Thymus gland morphology in children’s myasthenia]. In: Physiology, morphology and thymus pathology. Мoscow, 1986. Pp. 69–74. [In Russian].
5. Kuzin M.I., Gekht B.M. Miasteniya [Myasthenia]. Moscow: Meditsina; 1996. 224 p. [in Russian]
6. Laysek R.P., Barchi R.L. Miasteniya [Myasthenia]. Moscow: Meditsina; 1984. 272 p.
7. Sanadze AG. Miasteniya i miastenicheskie sindromy [Myasthenia gravis and myasthenic syndromes]. Moscow: Litera, 2012. 255 p. [in Russian]
8. Shcherbakovа N.I., Piradov М.А., Pavlovа Е.М. I dr. Prichiny, factory riska, prediktory razvitiya krizov u bol'nykh miasteniei [Reasons, risk factors, predictors of crisis in patients with myasthenia. Nevrologicheskii zhurnal [Neurologic Journal]. 2013. 2. pp.11–9. [In Russian].
9. Albdewi M.A., Liistro G., El Tahry R. Sleep-disordered breathing in patients with neuromuscular disease // Sleep Breath. 2017, Jul., 12
10. Bedlack R.S., Sanders D.B. On the concept of myasthenic crisis. J ClinNeuromuscul Dis 2002;4(1):40–2. PMID: 19078687.
11. Cohen M.S., Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann NY AcadSci 1981;377:670 – 7. PMID: 6951491.
12. Fatigue in myasthenia gravis: risk factors and impact on quality of life / Sarah Hoffmann, Johanna Ramm, Ulrike Grittner, Siegfried Kohler, Jana Siedler, and Andreas Meisel // Brain Behav. 2016. Vol. 6, N10. P. e00538.
13. Fernandes Oliveira E., Nacif S.R., Alves Pereira N., Fonseca N.T., Urbano J.J., Perez E.A., Cavalcante V., Santos Oliveira C., Insalaco G., Oliveira A.S., Oliveira L.V. Sleep disorders in patients with myasthenia gravis: a systematic review // J. Phys. Ther. Sci. 2015. Vol. 27, N6. P. 2013–2018.
14. Jani-Acsadi A., Lisak R.P. Myasthenic crisis: guidelines for prevention and treatment. J NeurolSci 2007; 261(1–2):127–33. PMID: 17544450.
15. Juel V.C., Massey J.M. Myasthenia gravis //Orphanet J Rare Dis 2007;2:44. PMID: 17986328.
16. Oopik M., Kaasik A.E., Jakobsen J.J. A population based epidemiological study on myasthenia gravis in Estonia // Neurol. Neurosurg. Psychiatry. 2003. № 74. P. 1638–1643.
17. Poulas K., Tsibr E., Kokta A. et al. Epidemiology of seropositive myasthenia gravis in Greece // J. Neurol. Neurosurg. Psychiatry. 2001. № 71. P. 352–356.
Number of Views: 285
Category of articles:
Clinical case
Bibliography link
Жаркинбекова Н.А., Мамыров А.М., Иргашева Б.Б. Случай успешного лечения криза при миастении у молодого пациента // Наука и Здравоохранение. 2019. 1 (Т.21).С. 111-115. Zharkinbekova N.A., Mamirov A.M., Irgasheva B.B. The case of successful treatment of a crisis in myastinic treatment in a young patient // Nauka i Zdravookhranenie [Science & Healthcare]. 2019, (Vol.21) 1, pp. 111-115. Жаркинбекова Н.А., Мамыров А.М., Иргашева Б.Б. Жас науқастағы миастениялық кризді он натижелі емдеу окиғасы // Ғылым және Денсаулық сақтау. 2019. 1 (Т.21). Б. 111-115.Related publications:
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES
GRANULOMATOUS POLYANGITIS (WEGENER’S GRANULOMATOSIS) IN THE PRACTICE OF A RHEUMATOGIST
VARIANT OF ADULT-ONSET STILL’SDISCASE: CASE REPORT
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2